Certified by Founder Lodge
Alto Neuroscience
United States - Los Altos, CA
START UP
1 Disclosed Funding Rounds $45,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alto Neuroscience is redefining psychiatry by developing personalized and highly effective medicines to help patients get better faster.
Our artificial intelligence (AI)-enabled platform
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 22 ,2023 | Series C | $45,000,000 |
Alkeon Capital Management
Alpha Wave Global, LP
What If Ventures
Eli Lilly and Company
Alexandria Real Estate Equities, Inc.
Windham Venture Partners
Franklin Templeton
Point72
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)